Aortic Valve Endocarditis. [Review]

Aortic Valve Endocarditis. [Review] - 2019

Copyright (c) 2019, StatPearls Publishing LLC. Infective endocarditis occurs globally and is the infection of the endocardial surface of the native valve, prosthetic heart valve, or an implanted cardiac device such as a permanent pacemaker or a cardioverter defibrillator.[1] Over the past few decades, there has been a change in both the host and the pathogen. Staphylococcus aureus has surpassed Streptococcus as the most common etiologic pathogen worldwide and especially in the developed world given its common association with health-care contact and invasive procedures. Changes in the host include older and sicker patients who carry a high burden of comorbidities. Resistance to antibiotics is another challenge threatening healthcare worldwide and seems to be growing. Despite technological advances in diagnostic and therapeutic modalities, the overall mortality has not improved. Aortic valve infective endocarditis is a life-threatening disease associated with high mortality and morbidity. In this chapter, we will provide an overview of the infective endocarditis with a particular emphasis on the aortic valve endocarditis. The term native valve endocarditis denotes a cardiac infection that involves the leaflets of the valves, the endocardial surface, chordae tendinae, congenital defects, and anastomosis sites. Prosthetic valve endocarditis is defined by an infection involving the artificial valves, conduits, catheters, assist devices, pacemakers, defibrillators, or other artificial intracardiac structures.


English


IN PROCESS -- NOT YET INDEXED


MedStar Heart & Vascular Institute


Review

Powered by Koha